Extensive scientific evidence from more than three decades of research has established that diminished cerebral glucose metabolism (DCGM; also known as glucose hypometabolism) is a key underlying pathological change in the Alzheimer’s brain.1 This leaves neurons less able to utilize glucose for fuel, leading to an energy shortage in the brain.1 DCGM occurs early in the disease and may contribute to symptoms and disease progression.1,6-8
Axona helps address this deficiency by providing ketones as an alternative fuel source for neurons.4,5 Axona is the only available prescription medical food that addresses DCGM.2,4 Adding Axona to traditional therapies addresses different aspects of Alzheimer’s disease at the same time and may help make the biggest impact in enhancing memory and cognition.4,5
Add Axona. Add what's been missing from Alzheimer's therapy.
Axona is a prescription medical food intended for the clinical dietary management of the metabolic processes associated with mild to moderate Alzheimer's disease.
Diminished cerebral glucose metabolism in Alzheimer's disease
Find out more about one of the earliest brain changes that occurs in Alzheimer's disease.1,7,8
Ketones: the brain's natural back-up fuel1